Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 41.70M | £ 132.50M | £ 24.80M | £ 25.80M | £ 206.80M |
Total Assets | £ 1.38B | £ 1.14B | £ 983.40M | £ 916.30M | £ 694.60M |
Total Debt | £ 439.70M | £ 402.30M | £ 254.50M | £ 261.80M | £ 33.70M |
Net Debt | £ 398.00M | £ 269.80M | £ 229.70M | £ 236.00M | £ -173.10M |
Total Liabilities | £ 710.80M | £ 590.90M | £ 442.40M | £ 416.00M | £ 163.90M |
Stockholders Equity | £ 662.00M | £ 547.70M | £ 536.30M | £ 496.20M | £ 527.00M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |